PMC:7261349 / 4261-6496
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T31 | 669-676 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T32 | 669-676 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T33 | 1234-1241 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T34 | 1234-1241 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T35 | 1340-1347 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T36 | 1340-1347 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T37 | 1428-1435 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T38 | 1428-1435 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
154 | 73-81 | Species | denotes | patients | Tax:9606 |
155 | 307-315 | Species | denotes | Patients | Tax:9606 |
156 | 398-408 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
157 | 469-477 | Species | denotes | patients | Tax:9606 |
158 | 577-583 | Chemical | denotes | oxygen | MESH:D010100 |
159 | 669-676 | Chemical | denotes | heparin | MESH:D006493 |
160 | 678-696 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
161 | 698-710 | Chemical | denotes | azithromycin | MESH:D017963 |
162 | 712-720 | Chemical | denotes | steroids | MESH:D013256 |
163 | 722-733 | Chemical | denotes | tocilizumab | MESH:C502936 |
164 | 752-761 | Chemical | denotes | lopinavir | MESH:D061466 |
165 | 782-793 | Chemical | denotes | oseltamivir | MESH:D053139 |
166 | 98-106 | Disease | denotes | Covid-19 | MESH:C000657245 |
167 | 1160-1169 | Disease | denotes | mortality | MESH:D003643 |
183 | 1196-1204 | Species | denotes | patients | Tax:9606 |
184 | 1287-1290 | Species | denotes | men | Tax:9606 |
185 | 1295-1300 | Species | denotes | women | Tax:9606 |
186 | 1234-1241 | Chemical | denotes | heparin | MESH:D006493 |
187 | 1340-1347 | Chemical | denotes | heparin | MESH:D006493 |
188 | 1428-1435 | Chemical | denotes | heparin | MESH:D006493 |
189 | 1611-1617 | Chemical | denotes | oxygen | MESH:D010100 |
190 | 1703-1721 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
191 | 1723-1735 | Chemical | denotes | azithromycin | MESH:D017963 |
192 | 1737-1745 | Chemical | denotes | steroids | MESH:D013256 |
193 | 1747-1758 | Chemical | denotes | tocilizumab | MESH:C502936 |
194 | 1777-1786 | Chemical | denotes | lopinavir | MESH:D061466 |
195 | 1792-1801 | Chemical | denotes | ritonavir | MESH:D019438 |
196 | 1806-1817 | Chemical | denotes | oseltamivir | MESH:D053139 |
197 | 1440-1449 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T22 | 669-676 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T23 | 1234-1241 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T24 | 1340-1347 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T25 | 1428-1435 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T7 | 398-406 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 294-300 | http://purl.obolibrary.org/obo/CLO_0009382 | denotes | Toledo |
T12 | 366-370 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T13 | 735-736 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 1262-1267 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T15 | 1378-1383 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T16 | 1468-1469 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 1760-1761 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T18 | 2115-2117 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T26 | 169-171 | Chemical | denotes | HM | http://purl.obolibrary.org/obo/CHEBI_74053 |
T27 | 577-583 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T28 | 669-676 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T29 | 678-696 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T30 | 698-710 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T31 | 712-720 | Chemical | denotes | steroids | http://purl.obolibrary.org/obo/CHEBI_35341 |
T32 | 722-733 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T33 | 752-761 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T34 | 767-776 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T35 | 782-793 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T36 | 933-938 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T37 | 1122-1127 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T38 | 1234-1241 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T39 | 1340-1347 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T40 | 1428-1435 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T41 | 1611-1617 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T42 | 1703-1721 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T43 | 1723-1735 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T44 | 1737-1745 | Chemical | denotes | steroids | http://purl.obolibrary.org/obo/CHEBI_35341 |
T45 | 1747-1758 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T46 | 1777-1786 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T47 | 1792-1801 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T48 | 1806-1817 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T49 | 2144-2146 | Chemical | denotes | HM | http://purl.obolibrary.org/obo/CHEBI_74053 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T36 | 0-7 | Sentence | denotes | Methods |
T37 | 8-198 | Sentence | denotes | Anonymized clinical records up to the 24th of April 2020, of all patients (n = 2075) with Covid-19, admitted in 17 Spanish hospitals, of the healthcare provider HM Hospitales, were reviewed. |
T38 | 199-306 | Sentence | denotes | These hospitals are based in the provinces of Barcelona, Coruña, León, Madrid, Pontevedra, and Toledo [10]. |
T39 | 307-462 | Sentence | denotes | Patients had been diagnosed with polymerase chain reaction test of respiratory samples for SARS-CoV-2, between the 1st of March and the 20th of April 2020. |
T40 | 463-525 | Sentence | denotes | Seven patients had been admitted before the 1st of March 2020. |
T41 | 526-810 | Sentence | denotes | Data on age, gender, temperature and saturation of oxygen at the time of admission, together with treatments at any time during admission with heparin, hydroxychloroquine, azithromycin, steroids, tocilizumab, a combination of lopinavir with ritonavir, and oseltamivir, were collected. |
T42 | 811-1013 | Sentence | denotes | The limited evidence on which these treatments were based, and the rapidly evolving clinical protocols, resulted in these drugs being given in many different specific preparations, doses, and frequency. |
T43 | 1014-1142 | Sentence | denotes | No information on dosage, duration of treatment, route of administration, or specific preparations of these drugs was collected. |
T44 | 1143-1184 | Sentence | denotes | Finally, data on mortality were recorded. |
T45 | 1185-1268 | Sentence | denotes | The age of patients treated and not treated with heparin was compared with t tests. |
T46 | 1269-1384 | Sentence | denotes | The proportion of men and women for those treated and not treated with heparin was compared with chi squared tests. |
T47 | 1385-1539 | Sentence | denotes | The association between the treatment with heparin and mortality was examined with a logistic regression model that was first adjusted for age and gender. |
T48 | 1540-1677 | Sentence | denotes | Second, two markers of severity, temperature > 37 °C and saturation of oxygen < 90% on admission, were introduced into the model as well. |
T49 | 1678-1843 | Sentence | denotes | Finally, treatments with hydroxychloroquine, azithromycin, steroids, tocilizumab, a combination of lopinavir with ritonavir, or oseltamivir, were added to the model. |
T50 | 1844-2078 | Sentence | denotes | Sensitivity analyses were made to compare estimates based on using missing data of severity markers as categories with, (1) estimates based on complete data dropping variables with missing observations, and (2) complete case analysis. |
T51 | 2079-2119 | Sentence | denotes | Stata 14 was used for the analysis [11]. |
T52 | 2120-2178 | Sentence | denotes | The ethics committee of HM Hospitales approved this study. |
T53 | 2179-2235 | Sentence | denotes | Data were anonymized before the authors could access it. |